REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?
The going has been strong for Regeneron Pharmaceuticals REGN over the past month. Shares of this biotech giant have surged 21.9% over the said time frame, outpacing the industry's growth of 4%. The stock has also outperformed the sector and the S&P 500 Index …
Sharemaestro market context Trend signal active 52 weeks +48.5% · Next-week setup positive 58.9%